retatrutide testing Test results on a popular unapproved peptide have revealed a concentration double that listed on the label, prompting warnings from health professionals about "enormous" overdose risks. By national health equity reporters Caitlyn Retatrutide in Chicago: The Next-Generation

You've found a medication that finally works, but then you see the price without insurance

Shes got no chill

[7] Two trials in the phase 3 TRIUMPH program reached primary completion in April 2026: TRIUMPH-1, a master protocol in adults with obesity or overweight, and TRIUMPH-3, in participants with severe obesity and established cardiovascular disease

When discussing a 50-pound weight loss target with your provider, share your genetic predispositions and baseline biomarkers from your PlexusDx genetic test

*This information is based on phase 3 clinical trial data and US prescribing information

The ocular story behind GLP-1s is getting messier